Literature DB >> 15740999

Anxiety and salivary cortisol in symptomatic and nonsymptomatic panic patients and healthy volunteers performing simulated public speaking.

Cybele Garcia-Leal1, Alexandre C B V Parente, Cristina M Del-Ben, Francisco S Guimarães, Ayrton Custódio Moreira, Lucila Leico Kagohara Elias, Frederico G Graeff.   

Abstract

Anxiety and salivary cortisol were measured in subjects performing simulated public speaking (SPS), a procedure that has been neurobiologically related to panic disorder. The subjects were divided into three groups: 18 symptomatic panic patients, 16 nonsymptomatic, drug-treated panic patients, and 17 healthy controls. In the experimental session, subjective anxiety (Visual Analogue Mood Scale) and the total score of the Bodily Symptom Scale (BSS) were higher in symptomatic patients than in controls, with nonsymptomatic patients in between. Measures of cortisol taken at home showed that the level was higher at 9:00 h than at 23:00 h in every group, indicating a normal circadian regulation of the hypothalamic-pituitary-adrenal (HPA) axis in panic patients. Also in every group, the level of cortisol was high at the beginning of the experimental session and decreased after 70 min. This fall parallels the decrease in anxiety and BSS ratings, and appears to reflect habituation of initial, anticipatory anxiety. Preparation and performance of speech raised anxiety and BSS scores to the initial levels, but failed to increase cortisol measured over 60 min, starting at the end of the speech. Therefore, SPS does not seem to activate the HPA axis, as reported in panic attacks.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15740999     DOI: 10.1016/j.psychres.2004.04.010

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  7 in total

Review 1.  Psychophysiological Markers of Fear and Anxiety.

Authors:  Jamiah Hyde; Katherine M Ryan; Allison M Waters
Journal:  Curr Psychiatry Rep       Date:  2019-06-04       Impact factor: 5.285

Review 2.  New perspective on the pathophysiology of panic: merging serotonin and opioids in the periaqueductal gray.

Authors:  F G Graeff
Journal:  Braz J Med Biol Res       Date:  2012-03-22       Impact factor: 2.590

3.  Cortisol awakening response in drug-naïve panic disorder.

Authors:  Katarzyna Jakuszkowiak-Wojten; Jerzy Landowski; Mariusz S Wiglusz; Wiesław Jerzy Cubała
Journal:  Neuropsychiatr Dis Treat       Date:  2016-06-27       Impact factor: 2.570

4.  Checking behavior in rhesus monkeys is related to anxiety and frontal activity.

Authors:  Marion Bosc; Bernard Bioulac; Nicolas Langbour; Tho Hai Nguyen; Michel Goillandeau; Benjamin Dehay; Pierre Burbaud; Thomas Michelet
Journal:  Sci Rep       Date:  2017-03-28       Impact factor: 4.379

5.  A yoga and compassion meditation program reduces stress in familial caregivers of Alzheimer's disease patients.

Authors:  M A D Danucalov; E H Kozasa; K T Ribas; J C F Galduróz; M C Garcia; I T N Verreschi; K C Oliveira; L Romani de Oliveira; J R Leite
Journal:  Evid Based Complement Alternat Med       Date:  2013-04-18       Impact factor: 2.629

Review 6.  Panic disorder: is the PAG involved?

Authors:  Cristina Marta Del-Ben; Frederico Guilherme Graeff
Journal:  Neural Plast       Date:  2009-03-10       Impact factor: 3.599

7.  Stress hormone response to the DEX-CRH test and its relation to psychotherapy outcome in panic disorder patients with and without agoraphobia.

Authors:  Susann Wichmann; Stefan R Bornstein; Thomas Lorenz; Katja Petrowski
Journal:  Transl Psychiatry       Date:  2018-02-02       Impact factor: 6.222

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.